abstract |
The present invention relates to c-Kit inhibitors useful for treating cancer, and other serine-threonine kinase-mediated diseases, having the following formula: Wherein A, L, R 1 , R 2 , R 3 , and n are described herein. The present invention is directed to inhibitors of the tyrosine protein kinase Kit (c-Kit) useful for treating diseases or disorders associated with c-Kit. Specifically, the present invention relates to compounds and compositions that inhibit c-Kit, methods for treating diseases or disorders associated with c-Kit, and methods for synthesizing these compounds. [Selection diagram] None |